Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03533972Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by Tatyasaheb Kore Dental College & Research Centre. Primary endpoints: C-Reactive Protein at 2 months, Superoxide Dismutase at 2 months and 2 more. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03533972.